Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Anti-Candidaalbicans germ tube antibodies reduce in vitro growth and biofilm formation of C. albicans.

Carrano G, Paulone S, Lainz L, Sevilla MJ, Blasi E, Moragues MD.

Rev Iberoam Micol. 2019 Jan - Mar;36(1):9-16. doi: 10.1016/j.riam.2018.07.005. Epub 2019 Jan 24.

PMID:
30686747
2.

Sequencing of FKS Hot Spot 1 from Saprochaete capitata To Search for a Relationship to Reduced Echinocandin Susceptibility.

Arrieta-Aguirre I, Menéndez-Manjón P, Cuétara MS, Fernández de Larrinoa I, García-Ruiz JC, Moragues MD.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01246-17. doi: 10.1128/AAC.01246-17. Print 2018 Feb.

3.

Molecular Identification of Saprochaete capitata in Human Blood and Paraffinized Tissue Samples.

Arrieta-Aguirre I, Menéndez-Manjón P, Cuétara MS, López-Soria L, García-Ruiz JC, Moragues MD.

J Clin Microbiol. 2017 Aug;55(8):2556-2559. doi: 10.1128/JCM.00876-17. Epub 2017 Jun 7. No abstract available.

4.

Disseminated fusariosis and hematologic malignancies, a still devastating association. Report of three new cases.

García-Ruiz JC, Olazábal I, Adán Pedroso RM, López-Soria L, Velasco-Benito V, Sánchez-Aparicio JA, Navajas A, Montejo M, Moragues MD.

Rev Iberoam Micol. 2015 Jul-Sep;32(3):190-6. doi: 10.1016/j.riam.2014.11.003. Epub 2015 Mar 25.

PMID:
25936697
5.

Humoral immunity links Candida albicans infection and celiac disease.

Corouge M, Loridant S, Fradin C, Salleron J, Damiens S, Moragues MD, Souplet V, Jouault T, Robert R, Dubucquoi S, Sendid B, Colombel JF, Poulain D.

PLoS One. 2015 Mar 20;10(3):e0121776. doi: 10.1371/journal.pone.0121776. eCollection 2015.

6.

Identification and characterization of nine atypical Candida dubliniensis clinical isolates.

Albaina O, Sahand IH, Brusca MI, Sullivan DJ, Fernández de Larrinoa I, Moragues MD.

J Med Microbiol. 2015 Feb;64(Pt 2):147-56. doi: 10.1099/jmm.0.078832-0. Epub 2014 Dec 5.

PMID:
25480879
7.
8.

An antibody reactivity-based assay for diagnosis of invasive candidiasis using protein array.

Ardizzoni A, Posteraro B, Baschieri MC, Bugli F, Sáez-Rosòn A, Manca L, Cacaci M, Paroni Sterbini F, De Waure C, Sevilla MJ, Peppoloni S, Sanguinetti M, Moragues MD, Blasi E.

Int J Immunopathol Pharmacol. 2014 Jul-Sep;27(3):403-12.

PMID:
25280031
9.

Candida albicans and cancer: Can this yeast induce cancer development or progression?

Ramirez-Garcia A, Rementeria A, Aguirre-Urizar JM, Moragues MD, Antoran A, Pellon A, Abad-Diaz-de-Cerio A, Hernando FL.

Crit Rev Microbiol. 2016;42(2):181-93. doi: 10.3109/1040841X.2014.913004. Epub 2014 Jun 25. Review.

PMID:
24963692
10.

Candida antigens and immune responses: implications for a vaccine.

Moragues MD, Rementeria A, Sevilla MJ, Eraso E, Quindos G.

Expert Rev Vaccines. 2014 Aug;13(8):1001-12. doi: 10.1586/14760584.2014.932253. Epub 2014 Jun 24. Review.

PMID:
24957934
11.

Anabolic steroids affect human periodontal health and microbiota.

Brusca MI, Verdugo F, Amighini C, Albaina O, Moragues MD.

Clin Oral Investig. 2014 Jul;18(6):1579-86. doi: 10.1007/s00784-013-1126-9. Epub 2013 Nov 13.

PMID:
24221579
12.

Invasive infections caused by Saprochaete capitata in patients with haematological malignancies: report of five cases and review of the antifungal therapy.

García-Ruiz JC, López-Soria L, Olazábal I, Amutio E, Arrieta-Aguirre I, Velasco-Benito V, Pontón J, Moragues MD.

Rev Iberoam Micol. 2013 Oct-Dec;30(4):248-55. doi: 10.1016/j.riam.2013.02.004. Epub 2013 Apr 11. Review.

PMID:
23583265
13.

Production of carcinogenic acetaldehyde by Candida albicans from patients with potentially malignant oral mucosal disorders.

Gainza-Cirauqui ML, Nieminen MT, Novak Frazer L, Aguirre-Urizar JM, Moragues MD, Rautemaa R.

J Oral Pathol Med. 2013 Mar;42(3):243-9. doi: 10.1111/j.1600-0714.2012.01203.x. Epub 2012 Aug 22.

PMID:
22909057
14.

Pga13 in Candida albicans is localized in the cell wall and influences cell surface properties, morphogenesis and virulence.

Gelis S, de Groot PW, Castillo L, Moragues MD, Sentandreu R, Gómez MM, Valentín E.

Fungal Genet Biol. 2012 Apr;49(4):322-31. doi: 10.1016/j.fgb.2012.01.010. Epub 2012 Feb 8.

PMID:
22343036
15.

Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.

Acosta J, Catalan M, del Palacio-Pérez-Medel A, Montejo JC, De-La-Cruz-Bértolo J, Moragues MD, Pontón J, Finkelman MA, del Palacio A.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):721-31. doi: 10.1007/s10096-011-1365-0. Epub 2011 Aug 3.

PMID:
21811868
16.

Periodontopathogen and Epstein-Barr virus contamination affects transplanted bone volume in sinus augmentation.

Verdugo F, Castillo A, Simonian K, Russo P, D'Addona A, Raffaelli L, Moragues MD, Quindós G, Pontón J.

J Periodontol. 2012 Feb;83(2):162-73. doi: 10.1902/jop.2011.110086. Epub 2011 May 16.

PMID:
21574831
17.

Fungicidal monoclonal antibody C7 interferes with iron acquisition in Candida albicans.

Brena S, Cabezas-Olcoz J, Moragues MD, Fernández de Larrinoa I, Domínguez A, Quindós G, Pontón J.

Antimicrob Agents Chemother. 2011 Jul;55(7):3156-63. doi: 10.1128/AAC.00892-10. Epub 2011 Apr 25.

18.

Bone microbial decontamination agents in osseous grafting: an in vitro study with fresh human explants.

Verdugo F, Sáez-Rosón A, Uribarri A, Martínez-Conde R, Cabezas-Olcoz J, Moragues MD, Pontón J.

J Periodontol. 2011 Jun;82(6):863-71. doi: 10.1902/jop.2010.100514. Epub 2010 Dec 7.

PMID:
21138353
19.

A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.

Acosta J, Catalan M, del Palacio-Peréz-Medel A, Lora D, Montejo JC, Cuetara MS, Moragues MD, Ponton J, del Palacio A.

Clin Microbiol Infect. 2011 Jul;17(7):1053-60. doi: 10.1111/j.1469-0691.2010.03357.x. Epub 2010 Nov 5.

20.

Potential of anti-Candida antibodies in immunoprophylaxis.

Cabezas J, Albaina O, Montañez D, Sevilla MJ, Moragues MD, Pontón J.

Immunotherapy. 2010 Mar;2(2):171-83. doi: 10.2217/imt.09.76. Review.

PMID:
20635926
21.

The impact of oral contraceptives on women's periodontal health and the subgingival occurrence of aggressive periodontopathogens and Candida species.

Brusca MI, Rosa A, Albaina O, Moragues MD, Verdugo F, Pontón J.

J Periodontol. 2010 Jul;81(7):1010-8. doi: 10.1902/jop.2010.090575.

PMID:
20370418
22.

Bone microbial contamination influences autogenous grafting in sinus augmentation.

Verdugo F, Castillo A, Moragues MD, Pontón J.

J Periodontol. 2009 Aug;80(8):1355-64. doi: 10.1902/jop.2009.090113.

PMID:
19656037
23.

Monoclonal antibody-mediated inhibition of adhesion of Candida albicans and Candida dubliniensis to human epithelial cells.

Elguezabal N, Maza JL, Moragues MD, Pontón J.

Eur J Oral Sci. 2009 Aug;117(4):474-8. doi: 10.1111/j.1600-0722.2009.00642.x.

PMID:
19627362
24.

Evaluation of CHROM-Pal medium for the isolation and direct identification of Candida dubliniensis in primary cultures from the oral cavity.

Sahand IH, Maza JL, Eraso E, Montejo M, Moragues MD, Aguirre JM, Quindós G, Pontón J.

J Med Microbiol. 2009 Nov;58(Pt 11):1437-42. doi: 10.1099/jmm.0.011320-0. Epub 2009 Jul 16.

PMID:
19608690
25.

Detection of (1-->3)-beta-D-glucan as an adjunct to diagnosis in a mixed population with uncommon proven invasive fungal diseases or with an unusual clinical presentation.

Cuétara MS, Alhambra A, Moragues MD, González-Elorza E, Pontón J, del Palacio A.

Clin Vaccine Immunol. 2009 Mar;16(3):423-6. doi: 10.1128/CVI.00009-09. Epub 2009 Jan 21.

26.

Isolation of Aspergillus lentulus in Spain from a critically ill patient with chronic obstructive pulmonary disease.

Alhambra A, Catalán M, Moragues MD, Brena S, Pontón J, Montejo JC, del Palacio A.

Rev Iberoam Micol. 2008 Dec 31;25(4):246-9.

27.

Use of a serum (1-->3)-beta-D-glucan assay for diagnosis and follow-up of Pneumocystis jiroveci pneumonia.

Cuétara MS, Alhambra A, Chaves F, Moragues MD, Pontón J, del Palacio A.

Clin Infect Dis. 2008 Nov 15;47(10):1364-6. doi: 10.1086/592753. No abstract available.

PMID:
18922079
28.

Contribution of serum biomarkers to the diagnosis of invasive candidiasis.

Laín A, Elguezabal N, Moragues MD, García-Ruiz JC, del Palacio A, Pontón J.

Expert Rev Mol Diagn. 2008 May;8(3):315-25. doi: 10.1586/14737159.8.3.315. Review.

PMID:
18598110
29.

Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities.

Polonelli L, Pontón J, Elguezabal N, Moragues MD, Casoli C, Pilotti E, Ronzi P, Dobroff AS, Rodrigues EG, Juliano MA, Maffei DL, Magliani W, Conti S, Travassos LR.

PLoS One. 2008 Jun 11;3(6):e2371. doi: 10.1371/journal.pone.0002371.

30.

Use of recombinant antigens for the diagnosis of invasive candidiasis.

Laín A, Elguezabal N, Amutio E, Fernández de Larrinoa I, Moragues MD, Pontón J.

Clin Dev Immunol. 2008;2008:721950. doi: 10.1155/2008/721950. Review.

31.

Cross-reactivity between Candida albicans and oral squamous cell carcinoma revealed by monoclonal antibody C7.

Rodríguez MJ, Schneider J, Moragues MD, Martínez-Conde R, Pontón J, Aguirre JM.

Anticancer Res. 2007 Sep-Oct;27(5B):3639-43.

32.

[Rapid identification of Candida dubliniensis using the Bichro-Dubli test].

Sahand IH, Ortiz R, Pemán J, Moragues MD, Quindós G, Pontón J.

Enferm Infecc Microbiol Clin. 2007 Nov;25(9):576-8. Spanish.

PMID:
17953898
33.

Fungicidal monoclonal antibody C7 binds to Candida albicans Als3.

Brena S, Omaetxebarría MJ, Elguezabal N, Cabezas J, Moragues MD, Pontón J.

Infect Immun. 2007 Jul;75(7):3680-2. Epub 2007 Apr 23.

34.

Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the N-terminal fragment of Candida albicans hyphal wall protein 1.

Laín A, Elguezabal N, Brena S, García-Ruiz JC, Del Palacio A, Moragues MD, Pontón J.

BMC Microbiol. 2007 Apr 21;7:35.

35.

Isolation of Issatchenkia occidentalis from the esophagus of a leukemic patient.

Sahand IH, Moragues MD, Alhambra A, del Palacio A, Quindós G, Pontón J.

Rev Iberoam Micol. 2006 Dec;23(4):235-7.

37.

Evaluation of a novel enzyme-linked immunosorbent assay to detect immunoglobulin G antibody to enolase for serodiagnosis of invasive candidiasis.

Laín A, Moragues MD, Ruiz JC, Mendoza J, Camacho A, Del Palacio A, Pontón J.

Clin Vaccine Immunol. 2007 Mar;14(3):318-9. Epub 2007 Jan 17.

38.

In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: comparison of CLSI M27-A2, Sensititre YeastOne, disk diffusion, and Etest methods.

Salgado-Parreño FJ, Alcoba-Flórez J, Arias A, Moragues MD, Quindós G, Pontón J, Arévalo MP.

Microb Drug Resist. 2006 Winter;12(4):246-51.

PMID:
17227209
39.

Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species.

Eraso E, Moragues MD, Villar-Vidal M, Sahand IH, González-Gómez N, Pontón J, Quindós G.

J Clin Microbiol. 2006 Sep;44(9):3340-5.

40.

Invasive aspergillosis due to subungual onychomycosis during treatment for non-Hodgkin lymphoma.

Cuétara MS, Alhambra A, Moreno JM, Postigo C, Moragues MD, Pontón J, del Palacio A.

Br J Dermatol. 2006 Jun;154(6):1200-2. No abstract available.

PMID:
16704657
41.

A fungicidal monoclonal antibody protects against murine invasive candidiasis.

Sevilla MJ, Robledo B, Rementeria A, Moragues MD, Pontón J.

Infect Immun. 2006 May;74(5):3042-5.

42.

Evaluation of Bichro-Dubli Fumouze to distinguish Candida dubliniensis from Candida albicans.

Sahand IH, Moragues MD, Robert R, Quindós G, Pontón J.

Diagn Microbiol Infect Dis. 2006 Jun;55(2):165-7. Epub 2006 Mar 9.

PMID:
16529902
43.

Supplementation of CHROMagar Candida medium with Pal's medium for rapid identification of Candida dubliniensis.

Sahand IH, Moragues MD, Eraso E, Villar-Vidal M, Quindós G, Pontón J.

J Clin Microbiol. 2005 Nov;43(11):5768-70.

44.

Serodiagnosis of mycoses using recombinant antigens.

Elguezabal N, Lopitz-Otsoa F, Laín A, de Larrinoa IF, Moragues MD, Pontón J.

Mycopathologia. 2005 Sep;160(2):97-109. Review.

PMID:
16170604
45.

Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.

Sánchez-Vargas LO, Ortiz-López NG, Villar M, Moragues MD, Aguirre JM, Cashat-Cruz M, Lopez-Ribot JL, Gaitán-Cepeda LA, Quindós G.

Rev Iberoam Micol. 2005 Jun;22(2):83-92.

46.

Oral Candida isolates colonizing or infecting human immunodeficiency virus-infected and healthy persons in Mexico.

Sánchez-Vargas LO, Ortiz-López NG, Villar M, Moragues MD, Aguirre JM, Cashat-Cruz M, Lopez-Ribot JL, Gaitán-Cepeda LA, Quindós G.

J Clin Microbiol. 2005 Aug;43(8):4159-62.

47.

Antifungal and antitumor activities of a monoclonal antibody directed against a stress mannoprotein of Candida albicans.

Omaetxebarría MJ, Moragues MD, Elguezabal N, Rodríguez-Alejandre A, Brena S, Schneider J, Polonelli L, Pontón J.

Curr Mol Med. 2005 Jun;5(4):393-401. Review.

PMID:
15977995
48.

Isolation of Candida dubliniensis in a teenager with denture stomatitis.

Mosca CO, Moragues MD, Brena S, Rosa AC, Pontón J.

Med Oral Patol Oral Cir Bucal. 2005 Jan-Feb;10(1):28-31; 25-8. English, Spanish.

49.

Specific antibody response in a patient with Candida dubliniensis fungemia.

Salesa R, Moragues MD, Sota R, Pemán J, Quindós G, Pontón J.

Rev Iberoam Micol. 2001 Mar;18(1):42-4.

50.

[Genotypes of Candida dubliniensis in clinical isolates].

Brena S, Rubio Mdel C, Salesa R, Iglesias I, Gil J, Rezusta A, Moragues MD, Pontón J.

Rev Iberoam Micol. 2004 Mar;21(1):20-3. Spanish.

Supplemental Content

Loading ...
Support Center